Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Neoplasms × anlotinib × Clear all

Phase

Status

Completed 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 21 Small Cell Lung Carcinoma 11 Sarcoma 7 Breast Neoplasms 7 Carcinoma, Hepatocellular 6 Lung Neoplasms 5 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 4 NSCLC 3 Glioma 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma 3 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Thyroid Neoplasms 2 Pheochromocytoma 2 Paraganglioma 2 Non-squamous Non-small Cell Lung Cancer 2 Neoplasms 2 Liver Neoplasms 2 Gynecological Cancer 2 Endometrial Neoplasms 2 Digestive System Neoplasms 2 Advanced Solid Tumor 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Cancer Limited Stage 1 Sarcoma, Ewing 1 SHR-1210 1 Recurrence 1

Interventions

Fluorouracil 68 Oxaliplatin 62 Leucovorin 53 Irinotecan 53 Capecitabine 51 Bevacizumab 51 Cetuximab 41 Folfox protocol 20 Drug Therapy 20 Neoadjuvant Therapy 18 HMPL-013 15 regorafenib 13 Colonoscopy 13 apatinib 11 XELOX 10 Chemotherapy, Adjuvant 10 raltitrexed 9 Radiotherapy 9 trifluridine tipiracil drug combination 8 sintilimab 8 Surveys and Questionnaires 8 Surgical Procedures, Operative 8 Panitumumab 8 IFL protocol 8 Blood Specimen Collection 8 tislelizumab 7 Laparoscopy 7 Endoscopic Mucosal Resection 7 Aspirin 7 Trastuzumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04970914 2022-03-08

ALTER-C003

Peking Union Medical College Hospital

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡